Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial
O'Brien, Katherine L, Prof, Chandran, Aruna, MD, Weatherholtz, Robert, BS, Jafri, Hasan S, MD, Griffin, M Pamela, MD, Bellamy, Terramika, MS, Millar, Eugene V, PhD, Jensen, Kathryn M, MS, Harris, Brian S, MS, Reid, Raymond, MD, Moulton, Lawrence H, PhD, Losonsky, Genevieve A, Karron, Ruth A, Prof, Santosham, Mathuram, Prof
Published in The Lancet infectious diseases (01.12.2015)
Published in The Lancet infectious diseases (01.12.2015)
Get full text
Journal Article